ExodusPoint Capital Management, LP - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 164 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$691
-86.8%
34,798
-88.6%
0.01%
-86.0%
Q1 2023$5,243
-99.1%
306,062
+718.3%
0.04%
+437.5%
Q3 2022$597,000
+145.7%
37,402
+111.6%
0.01%
+166.7%
Q2 2022$243,000
-25.2%
17,675
-13.8%
0.00%
-25.0%
Q1 2022$325,000
-83.6%
20,494
-43.2%
0.00%
-78.9%
Q4 2020$1,979,000
+192.8%
36,085
+22.0%
0.02%
+46.2%
Q3 2020$676,000
-4.4%
29,569
-4.8%
0.01%0.0%
Q4 2019$707,000
+381.0%
31,054
+146.5%
0.01%
+160.0%
Q3 2019$147,00012,6000.01%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 665,880$10,627,00011.09%
RTW INVESTMENTS, LP 15,802,802$252,213,0005.82%
Ally Bridge Group (NY) LLC 479,506$7,653,0005.05%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,204,0002.48%
TIGER MANAGEMENT L.L.C. 279,700$4,464,0001.95%
Prosight Management, LP 200,000$3,192,0001.71%
COWEN AND COMPANY, LLC 999,588$15,953,0001.53%
Boxer Capital, LLC 1,466,051$23,398,0001.32%
Affinity Asset Advisors, LLC 267,794$4,274,0001.19%
HARBOR CAPITAL ADVISORS, INC. 66,410$1,060,0000.97%
View complete list of ROCKET PHARMACEUTICALS INC shareholders